We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > tumour cells

News List

Grey Wolf raises £10m for tumour ‘illumination’ tech pharmaphorum
February 13, 2019
Immuno-oncology biotech Grey Wolf Therapeutics has raised £10 million in series A financing to develop therapies that increase tumour visibility.
Research by NCI determines necessary genes for cancer immunotherapy cphi-online
August 09, 2017
The research could accelarate the advancement of a new category of drugs.
RCSI and Almac Discovery enter research collaboration to target therapy-resistant cancer tumours firstwordpharma
February 15, 2017
RCSI (Royal College of Surgeons in Ireland) and Almac Discovery have today announced a major research collaboration that aims to gain a new understanding of how to target tumour cells that are resistant to cancer therapies and cause cancer to spread to ot